Title
Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
Authoring Organization
Publication Month/Year
August 25, 2022
Last Updated Month/Year
February 13, 2024
Supplemental Implementation Tools
Document Type
Consensus
Country of Publication
US
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Treatment, Management, Prevention
Diseases/Conditions (MeSH)
D002784 - Cholesterol, D050197 - Atherosclerosis, D008078 - Cholesterol, LDL, D008076 - Cholesterol, HDL
Keywords
atherosclerosis, atherosclerotic cardiovascular disease, dyslipidemia, LDL-cholesterol, PCSK9, lipids, nonstatin, LDL
Source Citation
Writing Committee, Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Covington AM, DePalma SM, Minissian MB, Orringer CE, Smith SC Jr, Waring AA, Wilkins JT. 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022 Aug 23:S0735-1097(22)05594-2. doi: 10.1016/j.jacc.2022.07.006. Epub ahead of print. PMID: 36031461.